Novavax

A person has received a combined Nuvaxovid (Novavax) COVID-19 booster and flu vaccination in one afternoon appointment, sharing it with hashtags about COVID-19 and vaccines. The post reflects the routine now possible in many places, where COVID and flu jabs can be given at the same visit. It joins the wider seasonal conversation about getting protected against both viruses ahead of winter.

Shares of Novavax, Emergent BioSolutions, Arcturus Therapeutics and Moderna are moving higher following reports that a lab worker in Russia died after contracting plague. Retail traders are speculating the incident could lead to government contract awards for vaccine developers, fueling the rally.

Novavax shares are being tracked by investors on the Frankfurt exchange under ticker NVV1.F, where the biotech's price, quote and history are being monitored amid ongoing interest in the company's outlook. Novavax, known for its COVID-19 vaccine business, has faced volatile trading in recent years as it works to stabilise revenue, and market watchers are following its stock movements closely.